Author

Ségolène Duran

Observed names: DURAN, Ségolène, Segolene Duran

Observed institutions: Inserm, Institut Paoli-Calmettes

OpenAlex ID: A5109206562

Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach

2002 · Bruno Spire, Ségolène Duran, et al. · Social Science & Medicine · 296

Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy

2001 · Ségolène Duran, Marianne Savès, et al. · AIDS · 284

Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAART

2001 · Ségolène Duran, Bruno Spire, et al. · HIV Clinical Trials · 218

De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study

2013 · Djamel Mokart, Géraldine Slehofer, et al. · Intensive Care Medicine · 136

2003 · Patrizia Carrieri, Bruno Spire, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 135

Brentuximab vedotin followed by allogeneic transplantation as salvage regimen in patients with relapsed and/or refractory Hodgkin's lymphoma

2013 · Sylvain Garciaz, Diane Coso, et al. · Hematological Oncology · 47

Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma

2012 · Jean El-Cheikh, Roberto Crocchiolo, et al. · Experimental Hematology · 46

PDF

‘Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?’ A comparison between patients’ self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study

2001 · Ségolène Duran, Caroline Solas, et al. · AIDS · 39

Impact of Discontinuation of Initial Protease Inhibitor Therapy on Further Virological Response in a Cohort of Human Immunodeficiency Virus–Infected Patients

2002 · Vincent Le Moing, Geneviève Chêne, et al. · Clinical Infectious Diseases · 27

Mechanisms of Early Virologic Failure in Antiretroviral‐Naive Patients Starting Protease Inhibitor–Containing Regimens: The APROVIR Study

2002 · Bernard Masquelier, Gilles Peytavin, et al. · The Journal of Infectious Diseases · 25

Nivolumab in routine practice for older patients with advanced or metastatic non-small cell lung cancer

2018 · Renaud Sabatier, Emanuel Nicolas, et al. · Journal of Geriatric Oncology · 24

Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation

2010 · Jean El Cheikh, Luca Castagna, et al. · Hematology/Oncology and Stem Cell Therapy · 22

PDF

The use of ‘added benefit’ to determine the price of new anti-cancer drugs in France, 2004–2017

2021 · Marc A. Rodwin, Julien Mancini, et al. · European Journal of Cancer · 18

The detection of non-adherence by self-administered questionnaires can be optimized by protease inhibitor plasma concentration determination

2003 · Ségolène Duran, Gilles Peytavin, et al. · AIDS · 18

Self-management Strategies Adopted by Breast Cancer Survivors to Improve their Adherence to Tamoxifen

2012 · Aline Sarradon-Eck, Isabelle Pellegrini, et al. · The Breast Journal · 6

PDF

Corrigendum to “The use of ‘added benefit’ to determine the price of new anti-cancer drugs in France, 2004–2017” [Eur J Canc 145 (2021) 11–18]

2021 · Marc A. Rodwin, Julien Mancini, et al. · European Journal of Cancer · 3

PDF

Features and Risk Factors of Peripheral Neuropathy during Treatment of Advanced Multiple Myeloma with Bortezomib.

2006 · Jean El-Cheikh, Anne Marie Stoppa, et al. · Blood · 2

Efficacy and Safety of Micafungin for Prophylaxis of Invasive Fungal Infections in Patients Undergoing Haplo-Identical Hematopoietic Stem Cell Transplant

2012 · Jean El-Cheikh, Geoffroy Venton, et al. · Blood

Lenalidomide Followed with Donor Lymphocytes Infusion (DLI) After Allogeneic Stem-Cell Transplantation (Allo-SCT) with Reduced-Intensity Conditioning in Patients with High Risk Multiple Myeloma

2011 · Jean El-Cheikh, Roberto Crocchiolo, et al. · Blood

Works count: 23

Citation count: 1,346

H-index: 14

I10-index: 14